Translational Development Acquisition Corp.

Translational Development Acquisition Corp.

TDAC·NASDAQ

$10.74

-0.19%
Financial ServicesShell Companies

Translational Development Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.

At a Glance

Live Snapshot
Market Cap$235.29M
EPS0.3700
P/E Ratio29.03
Earnings Date05/15/2026

tdac

Common Stock

Last Annual Value

181.66M

3-Year CAGR

7205%

5-Year CAGR

1213%

10-Year CAGR

262%

Translational Development Acquisition Corp.

Translational Development Acquisition Corp. Competitors Analysis of Common Stock

TDAC · NASDAQ
CompanyCommon Stock
CAGR 3Y
CAGR 5Y
CAGR 10Y
181.66M
7205.0%N/AN/A 
210.51M
7395.0%N/AN/A
237.01M
N/A8.4%N/A
183.79M
2872.2%-11.8%N/A
297.62M
N/A1142.3%N/A
181.85M
N/AN/AN/A
Translational Development Acquisition Corp.

Translational Development Acquisition Corp. Fair Value Envelope

TDAC · NASDAQ

Our analysis suggests that TDAC has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $10.74, this represents a potential HIDDEN relative to our calculated worth for Translational Development Acquisition Corp..

Intrinsic Value
Current Price: $10.74